STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] Assertio Holdings, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Assertio Holdings (ASRT)500,000 restricted stock units and 1,000,000 stock options granted.

The options carry a $0.8248 exercise price and expire on 11/13/2035. RSUs are tied to one share each and carry an end date of 11/13/2028. Both awards vest in three equal installments on each of the first three anniversaries of the grant date, contingent on continued employment. The grants were awarded for no cash consideration.

Positive
  • None.
Negative
  • None.

Insights

Routine CEO grants: 500k RSUs, 1.0M options at $0.8248, 3-year vest.

The reported awards are standard long-term incentive components: time‑based RSUs and stock options. RSUs deliver one share per unit, while options only have value above the $0.8248 exercise price.

Vesting occurs in three equal tranches on each of the first three anniversaries of the 11/13/2025 grant, aligning retention incentives with service. The options expire on 11/13/2035 and RSUs are listed through 11/13/2028. Actual realized value will depend on future share price and continued employment.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Reisenauer Mark L

(Last) (First) (Middle)
ASSERTIO HOLDINGS, INC.
100 SOUTH SAUNDERS ROAD, SUITE 300

(Street)
LAKE FOREST IL 60045

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Assertio Holdings, Inc. [ ASRT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
CEO
3. Date of Earliest Transaction (Month/Day/Year)
11/13/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units $0(1) 11/13/2025 A 500,000 (2) 11/13/2028 Common Stock 500,000 $0(3) 500,000 D
Stock Option (Right to Buy) $0.8248 11/13/2025 A 1,000,000 (2) 11/13/2035 Common Stock 1,000,000 $0(3) 1,000,000 D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of the registrant's common stock.
2. One-third of these restricted stock units and stock options are scheduled to vest on each of the first three anniversaries of the grant date, assuming continued employment through the applicable vesting date.
3. The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities.
/s/ Sam Schlessinger, Attorney-in-fact for Mark L. Reisenauer 11/14/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did ASRT report?

The CEO received 500,000 RSUs and 1,000,000 stock options on 11/13/2025.

What is the exercise price of the ASRT stock options?

The options have an exercise price of $0.8248 per share.

How do the ASRT CEO’s awards vest?

Both the RSUs and options vest one‑third on each of the first three anniversaries of the grant date, subject to continued employment.

When do the awards expire?

The RSUs are listed through 11/13/2028, and the stock options expire on 11/13/2035.

Did the CEO pay for these awards?

No. The filing states the awards were granted for $0 consideration.

How many derivative securities are shown as beneficially owned after the grants?

The filing lists 500,000 RSUs and 1,000,000 stock options as beneficially owned directly.
Assertio Holdings Inc

NASDAQ:ASRT

ASRT Rankings

ASRT Latest News

ASRT Latest SEC Filings

ASRT Stock Data

79.39M
93.74M
2.51%
26.86%
5.02%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
LAKE FOREST